Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Basic calcium phosphate disease

Rheumatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
A destructive or septic-appearing shoulder

A hot swollen shoulder with fever, systemic illness, recent surgery or injection, immunosuppression, bacteraemia risk or rapidly progressive loss of function must be treated as possible septic arthritis; major trauma, neurovascular compromise and acute cuff failure are additional emergencies.

Action: Arrange same-day hospital assessment, obtain blood cultures when febrile and aspirate an accessible effusion for cell count, Gram stain, culture and crystal assessment before antibiotics when safe; do not attribute the presentation to a visible calcium deposit or inject corticosteroid until infection has been reasonably excluded.

Synopsis

Recognise the different syndromes produced by basic calcium phosphate deposition, distinguish focal calcific periarthritis from infection and cuff disease, and use imaging, aspiration and staged conservative or procedural treatment safely.

  • Basic calcium phosphate includes hydroxyapatite and produces calcific tendinopathy, acute calcific periarthritis, destructive Milwaukee shoulder and crystal-associated osteoarthritis.
  • The usual presentation is severe focal shoulder pain from a resorbing rotator-cuff deposit, but deposits can be asymptomatic and may occur around other joints.
  • Routine polarised microscopy does not visualise basic calcium phosphate crystals; a negative crystal report therefore does not exclude the disorder.
  • Initial imaging for suspected calcific tendinopathy usually includes a plain radiograph; ultrasound localises the deposit, evaluates the cuff and guides aspiration, injection or lavage.
  • First-line care is explanation, short relative rest during extreme pain, early range restoration, graded tendon loading and topical or brief oral analgesia matched to risk.
  • For one inflamed bursa or joint, ultrasound-guided aspiration and corticosteroid injection is considered only after infection has been excluded and the tendon itself is avoided.
  • Persistent symptomatic focal deposits may be considered for ultrasound-guided needling and lavage; extracorporeal shockwave therapy should be used only in research under current NICE guidance.

Key red flags

Fever, rigors, hypotension, an acutely hot effusion or severe pain on passive movement requires urgent septic-arthritis assessment even when calcification is visible.

Recent trauma with inability to abduct, contour change, bony tenderness or neurovascular deficit raises fracture, dislocation or acute rotator-cuff tear rather than uncomplicated calcific tendinopathy.

Rapid joint destruction, a large recurrent haemorrhagic effusion and profound cuff weakness in an older adult suggests Milwaukee shoulder and warrants specialist imaging and aspiration.

A calcified periarticular mass that is enlarging, unusually located or associated with hypercalcaemia, renal failure or skin breakdown needs investigation for tumour, tumoral calcinosis or metastatic calcification.

Night pain, weight loss, previous cancer or a destructive bone lesion is not explained by an incidental tendon deposit and needs an urgent malignancy pathway.

Progressive objective weakness, cervical neurological signs or a persistently pseudoparalytic shoulder requires assessment for full-thickness cuff failure or neurological disease.

Milwaukee shoulder

An older person, often a woman, develops major painless or painful swelling, recurrent large haemorrhagic effusions, crepitus, instability and profound active-movement loss from cuff failure and rapid destruction.

Investigation priorities

01
Initial plain radiographFirst step

Confirm a peri-tendinous calcium deposit and assess bone, alignment and destructive change.

Management branches

First diagnostic stepMatch radiograph to phenotype

Focal atraumatic shoulder or periarticular pain suggests calcific disease without systemic instability.

  1. Examine active and passive movement, cuff strength, focal tendon and bursal tenderness, neck and neurovascular status and sepsis or trauma features.
  2. Request plain radiographs first and use ultrasound when the deposit, bursa or tendon must be localised or a tear or guided procedure is being considered.
  3. Treat the opacity as causal only when its site, inflammatory phase and clinical pattern agree; pursue adhesive capsulitis, cuff tear, referred pain or OA otherwise.
First-line symptomatic careProtect briefly, then reload

A symptomatic deposit has no red flag or major tear and function can be managed conservatively.

  1. Explain the often self-limiting resorptive phase, use ice or heat by preference and allow only short relative rest during intolerable pain.
  2. Start comfortable range-of-motion work early, then progressive cuff and scapular loading with physiotherapy and work or sleep modification.
  3. Offer topical NSAID first where suitable; use a brief oral NSAID or paracetamol only after individual renal, gut, cardiovascular, bleeding and pregnancy assessment.

Key medicines

Diclofenac 1.16% gelApply 2 to 4 g to the painful area three or four times daily, gently rubbing it in; use the smallest area and shortest duration needed and wash the hands afterwards unless they are treated.Avoid broken skin, NSAID hypersensitivity and use with another NSAID without review. Systemic renal, gastrointestinal and cardiovascular effects remain possible with extensive or prolonged use. Avoid in the third trimester of pregnancy and seek medicine-specific advice earlier in pregnancy or while breastfeeding.
NaproxenFor a severe inflammatory episode, a common off-label short course is 250 to 500 mg orally twice daily with food for 3 to 5 days, at the lowest effective dose; add a proton-pump inhibitor when gastrointestinal risk warrants it.Avoid active ulcer, severe renal, hepatic or heart failure, NSAID hypersensitivity, concurrent NSAIDs and major bleeding risk. Review anticoagulants, ACE inhibitor or ARB plus diuretic exposure. Avoid from 20 weeks of pregnancy unless essential and do not use in the final trimester.
Open full textbook →Answer 2 questions
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Basic calcium phosphate crystal-associated musculoskeletal syndromesClinical phenotypes, crystal biology, microscopy limitations and Milwaukee shoulder.
  • NICE HTG645: extracorporeal shockwave therapy for calcific tendinopathy in the shoulderCurrent only-in-research recommendation and safety-efficacy distinction.
  • EULAR imaging recommendations for crystal-induced arthropathiesRoles and limitations of conventional radiography, ultrasound and advanced imaging.
  • Kenalog intra-articular and intramuscular injection UK product informationDose range, asepsis, infection, glucose, pregnancy and tendon cautions.
  • Voltarol 1.16% gel UK product informationTopical diclofenac dosing, contraindications and reproductive safety.
  • Naproxen UK product informationOral dosing and renal, gastrointestinal, cardiovascular and pregnancy restrictions.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting review
JurisdictionUnited Kingdom